27 results

e83 The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4
Kyung Hee Han, Noh Hyun Park, Jin Ju Kim, Sunmie Kim, Hee Seung Kim, Maria Lee, Yong Sang Song
KMSID: 1134472   J Gynecol Oncol. 2019;30(6):e83.  Published online 2019 May 20    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e83
         
e85 Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
Kosuke Yoshida, Nobuhisa Yoshikawa, Akira Shirakawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka Kikkawa
KMSID: 1134473   J Gynecol Oncol. 2019;30(6):e85.  Published online 2019 April 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e85
         
e88 A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
Young-Chul Park, Yung-Taek Ouh, Moon-Hee Sung, Hong-Gyu Park, Tae-Jin Kim, Chi-Heum Cho, Jong Sup Park, Jae-Kwan Lee
KMSID: 1134474   J Gynecol Oncol. 2019;30(6):e88.  Published online 2019 May 2    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e88
         
e89 Prognostic value of metabolic tumor volume and total lesion glycolysis from 18 F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma
Dou-dou Liu, Jianfang Li, Xiaomao Li, Liangjun Xie, Luping Qin, Fangyu Peng, Mu-hua Cheng
KMSID: 1134475   J Gynecol Oncol. 2019;30(6):e89.  Published online 2019 November 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e89
         
e90 Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
Akira Mitsuhashi, Yuji Habu, Tatsuya Kobayashi, Yoshimasa Kawarai, Hiroshi Ishikawa, Hirokazu Usui, Makio Shozu
KMSID: 1134476   J Gynecol Oncol. 2019;30(6):e90.  Published online 2019 May 20    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e90
         
e93 Evaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer
Laura Moulton Chambers, Ji Son, Milena Radeva, Robert DeBernardo
KMSID: 1134477   J Gynecol Oncol. 2019;30(6):e93.  Published online 2019 May 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e93
         
e94 Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
Alice Indini, Lorenza Di Guardo, Carolina Cimminiello, Domenica Lorusso, Francesco Raspagliesi, Michele Del Vecchio
KMSID: 1134478   J Gynecol Oncol. 2019;30(6):e94.  Published online 2019 May 13    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e94
         
e95 Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors
Jeong-Yeol Park, Sang-Hun Lee, Kyu-Rae Kim, Young-Tak Kim, Joo-Hyun Nam
KMSID: 1134479   J Gynecol Oncol. 2019;30(6):e95.  Published online 2019 November 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e95
         
e96 Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women
Tsutomu Ida, Hiroyuki Fujiwara, Takahiro Kiriu, Yoshimi Taniguchi, Akira Kohyama
KMSID: 1134480   J Gynecol Oncol. 2019;30(6):e96.  Published online 2019 June 3    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e96
         
e99 Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis
Hongyan Cheng, Lanqing Huo, Dan Wang, Yang Xiang
KMSID: 1134481   J Gynecol Oncol. 2019;30(6):e99.  Published online 2019 June 10    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e99
         
e100 The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
Makiko So, Taito Miyamoto, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masaki Mandai
KMSID: 1134459   J Gynecol Oncol. 2019;30(6):e100.  Published online 2019 June 10    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e100
         
e102 Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis
Masato Yoshihara, Hiroaki Kajiyama, Satoshi Tamauchi, Shiro Suzuki, Kunihiko Takahashi, Shigeyuki Matsui, Fumitaka Kikkawa
KMSID: 1134460   J Gynecol Oncol. 2019;30(6):e102.  Published online 2019 June 26    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e102
         
e103 Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
Harunobu Matsumoto, Mototsugu Shimokawa, Kaei Nasu, Ayumi Shikama, Takaya Shiozaki, Masayuki Futagami, Kentaro Kai, Hiroaki Nagano, Taisuke Mori, Mitsutake Yano, Norihiro Sugino, Etsuko Fujimoto, Norihito Yoshioka, Satoshi Nakagawa, Muneaki Shimada, Hideki Tokunaga, Yuki Yamada, Tomohiko Tsuruta, Kazuto Tasaki, Ryutaro Nishikawa, Shiho Kuji, Takashi Motohashi, Kimihiko Ito, Takashi Yamada, Norihiro Teramoto
KMSID: 1134461   J Gynecol Oncol. 2019;30(6):e103.  Published online 2019 July 1    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e103
         
e110 Reviewer recognition in 2019
KMSID: 1134462   J Gynecol Oncol. 2019;30(6):e110.  Published online 2019 November 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e110
         
e111 Comments on: Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
Thales Paulo Batista, Shigeki Kusamura
KMSID: 1134463   J Gynecol Oncol. 2019;30(6):e111.  Published online 2019 August 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e111
         
e112 A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
Jung-Yun Lee, Jae Weon Kim, Myong Cheol Lim, Sunghoon Kim, Hee Seung Kim, Chel Hun Choi, Ju Yeon Yi, Sang-Yoon Park, Byoung-Gie Kim,
KMSID: 1134464   J Gynecol Oncol. 2019;30(6):e112.  Published online 2019 September 3    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e112
         
e113 Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
Hiroko Machida, Koji Matsuo, Takayuki Enomoto, Mikio Mikami
KMSID: 1134465   J Gynecol Oncol. 2019;30(6):e113.  Published online 2019 September 3    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e113
         
e114 The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO)
Kosuke Yoshihara, Masayuki Sekine, Koji Nishino, Takayuki Enomoto
KMSID: 1134466   J Gynecol Oncol. 2019;30(6):e114.  Published online 2019 September 2    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e114
         
e115 ASGO, KSGO, and JSGO announce collaboration
KMSID: 1134467   J Gynecol Oncol. 2019;30(6):e115.  Published online 2019 November 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e115
         
e116 Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
Rongyu Zang, Jianqing Zhu
KMSID: 1134468   J Gynecol Oncol. 2019;30(6):e116.  Published online 2019 September 16    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e116
         
e117 Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy
Kimio Ushijima
KMSID: 1134469   J Gynecol Oncol. 2019;30(6):e117.  Published online 2019 September 11    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e117
         
e118 The Annual Meeting of the Thai Gynecologic Cancer Society 2019: Meeting report
Kittipat Charoenkwan, Jatupol Srisomboon
KMSID: 1134470   J Gynecol Oncol. 2019;30(6):e118.  Published online 2019 September 20    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e118
         
e119 Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
Krishnansu S. Tewari
KMSID: 1134471   J Gynecol Oncol. 2019;30(6):e119.  Published online 2019 September 20    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e119
         
e89 Prognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma
Dou-dou Liu, Jianfang Li, Xiaomao Li, Liangjun Xie, Luping Qin, Fangyu Peng, Mu-hua Cheng
KMSID: 1148324   J Gynecol Oncol. 2019;30(6):e89.  Published online 2019 June 11    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e89
         
e95 Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors
Jeong-Yeol Park, Sang-Hun Lee, Kyu-Rae Kim, Young-Tak Kim, Joo-Hyun Nam
KMSID: 1148325   J Gynecol Oncol. 2019;30(6):e95.  Published online 2019 May 20    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e95
         
e110 Reviewer recognition in 2019
KMSID: 1148314   J Gynecol Oncol. 2019;30(6):e110.  Published online 2019 August 20    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e110
         
e115 ASGO, KSGO, and JSGO announce collaboration
KMSID: 1148315   J Gynecol Oncol. 2019;30(6):e115.  Published online 2019 September 20    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e115
         
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology